July 10, 2025

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Strategic Opportunity with 28% Upside Potential

Nerdy Inc. (NRDY), a prominent player in the technology sector, is making waves with its innovative approach to online learning. With its headquarters nestled in Saint..

Viant Technology Inc. (DSP) Stock Analysis: Insights into a Potential 53% Upside for Tech Investors

Viant Technology Inc. (NASDAQ: DSP) has garnered significant attention in the tech investment community, and for good reason. With a market capitalization of $887.82 million, the..

Cytek Biosciences (CTKB) Stock Analysis: 60% Potential Upside Amid Healthcare Innovations

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands as a notable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $453.44..

Grab Holdings Limited (GRAB) Stock Analysis: Strong Buy Ratings and 16% Potential Upside

Grab Holdings Limited (GRAB), a dominant player in the Southeast Asian “superapp” space, continues to capture investor attention with its diverse service offerings across mobility, deliveries,..

Pacific Biosciences of California (PACB) Stock Analysis: Is the 38.85% Potential Upside Worth the Risk?

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a prominent player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Menlo..

Alpha Tau Medical Ltd. (DRTS): Investor Outlook Reveals 168% Potential Upside with Promising Oncology Innovations

Alpha Tau Medical Ltd. (NASDAQ: DRTS), headquartered in Jerusalem, Israel, is carving a niche in the healthcare sector with its innovative approach to oncology therapeutics. Focused..

Marti Technologies, Inc. (MRT) Stock Analysis: A Look at the 78% Upside Potential

Marti Technologies, Inc. (NASDAQ: MRT) is attracting attention in the investment community, driven by its innovative approach to urban transportation in Turkey and an enticing 78%..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Unveiling a Potential 382% Upside

Compass Therapeutics, Inc. (NASDAQ: CMPX), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is capturing the attention of investors with its innovative approach in the biotechnology..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Biotech Innovator Positioned for Growth Amidst Clinical Advances

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is gaining traction in the biotechnology sector with its innovative approach to targeting genetically defined diseases. This clinical-stage biopharmaceutical company, headquartered..

Aurora Cannabis Inc. (ACB): Investor Outlook Highlights Revenue Growth and Analyst Ratings

Aurora Cannabis Inc. (ACB), a prominent player in the healthcare sector, specializes in the production, distribution, and sale of cannabis and cannabis-derivative products. With its headquarters..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech Gem with 355% Upside Potential

For investors with a keen eye on the biotechnology sector, Arcturus Therapeutics Holdings (NASDAQ: ARCT) presents an intriguing opportunity. With a market capitalization of $401.11 million,..

Varex Imaging Corporation (VREX) Stock Analysis: A Healthcare Imaging Leader With Nearly 97% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX) stands as a notable player in the healthcare sector, particularly within the medical devices industry. The company, headquartered in Salt Lake..

TotalEnergies SE (TTE) Stock Analysis: A Strong Dividend Play with a 10.96% Upside Potential

TotalEnergies SE (TTE) stands as a formidable player in the global energy sector, offering a diverse portfolio that spans oil, biofuels, natural gas, and renewable energy..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 95% Potential Upside in the Medical Device Sector

Neuronetics, Inc. (NASDAQ: STIM), a key player in the medical device industry, is capturing investor attention with its innovative approach to treating neurohealth disorders and a..

Gossamer Bio, Inc. (GOSS) Stock Report: Analysts See a Potential Upside of 459%—Is It Worth the Risk?

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company headquartered in San Diego, California, operates within the healthcare sector, focusing on groundbreaking treatments for pulmonary arterial..

Candel Therapeutics, Inc. (CADL) Stock Analysis: A Promising 261% Upside Potential with Robust Analyst Support

Candel Therapeutics, Inc. (NASDAQ: CADL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising portfolio of cancer immunotherapies. Headquartered in Needham,..

XOMA Royalty Corporation (XOMA) Stock Analysis: A Biotech Gem with 133% Potential Upside

As investors sift through the myriad opportunities in the healthcare sector, XOMA Royalty Corporation (NASDAQ: XOMA) stands out with a compelling growth narrative anchored by a..

NANO-X IMAGING LTD (NNOX): Investor Outlook Reveals 67.95% Potential Upside in the Innovative Medical Imaging Sector

Nano-X Imaging Ltd (NASDAQ: NNOX) is capturing investor attention with its groundbreaking approach to medical imaging technology. Headquartered in Petah Tikva, Israel, this trailblazer in the..

National Research Corporation (NRC) Stock Analysis: A High ROE Healthcare Play with a 2.86% Dividend Yield

National Research Corporation (NRC), a key player in the healthcare sector, specializes in providing analytics and insights designed to enhance the patient and employee experience. With..

Exxon Mobil Corporation (XOM) Stock Analysis: Assessing a 9% Potential Upside

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to be a focal point for investors seeking stability and growth in the oil..

Search

Funds

July 10, 2025

Search

Funds

July 10, 2025

FTSE 100

Funds